Literature DB >> 20308390

In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Lucio Vera-Cabrera1, Mayra Paola Campos-Rivera, Wendy G Escalante-Fuentes, Michael J Pucci, Jorge Ocampo-Candiani, Oliverio Welsh.   

Abstract

The in vitro activities of ACH-702 and other antimicrobials against 30 Nocardia brasiliensis isolates were tested. The MIC(50) (MIC for 50% of the strains tested) and MIC(90) values of ACH-702 were 0.125 and 0.5 microg/ml. The same values for econazole were 2 and 4 microg/ml. The MIC(50) and MIC(90) values of imipenem and meropenem were 64 and >64 microg/ml and 2 and 8 microg/ml, respectively; the addition of clavulanic acid to the carbapenems had no effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308390      PMCID: PMC2863655          DOI: 10.1128/AAC.01520-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline.

Authors:  P M Bath; K W Pettingale; J Wade
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.

Authors:  Zahoor Ahmad; Sadhna Sharma; G K Khuller; Pushpendra Singh; Jaya Faujdar; V M Katoch
Journal:  Int J Antimicrob Agents       Date:  2006-11-13       Impact factor: 5.283

3.  Two cases of Nocardia asteroides sternotomy infection treated with ofloxacin and a review of other active antimicrobial agents.

Authors:  W W Yew; P C Wong; S Y Kwan; C Y Chan; M S Li
Journal:  J Infect       Date:  1991-11       Impact factor: 6.072

4.  [Actinomycetoma and Nocardia sp. Report of five cases treated with imipenem or imipenem plus amikacin].

Authors:  Adán Fuentes; Roberto Arenas; Miguel Reyes; Ramón F Fernández; Rogelio Zacarías
Journal:  Gac Med Mex       Date:  2006 May-Jun       Impact factor: 0.302

5.  New classification and update on the quinolone antibiotics.

Authors:  D E King; R Malone; S H Lilley
Journal:  Am Fam Physician       Date:  2000-05-01       Impact factor: 3.292

6.  Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.

Authors:  M Dreetz; J Hamacher; J Eller; K Borner; P Koeppe; T Schaberg; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

7.  Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.

Authors:  Zahoor Ahmad; Sadhna Sharma; G K Khuller
Journal:  FEMS Microbiol Lett       Date:  2006-08       Impact factor: 2.742

8.  Distribution of a Nocardia brasiliensis catalase gene fragment in members of the genera Nocardia, Gordona, and Rhodococcus.

Authors:  L Vera-Cabrera; W M Johnson; O Welsh; F L Resendiz-Uresti; M C Salinas-Carmona
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

9.  Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages.

Authors:  Lucio Vera-Cabrera; Nelly A Espinoza-González; Oliverio Welsh; Jorge Ocampo-Candiani; Jorge Castro-Garza
Journal:  J Antimicrob Chemother       Date:  2009-08-26       Impact factor: 5.790

10.  In vitro activities of new antimicrobials against Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Sung H Choi; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more
  7 in total

1.  Complete genome sequence of Nocardia brasiliensis HUJEG-1.

Authors:  Lucio Vera-Cabrera; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Antonio Ali Perez-Maya; Jorge Ocampo-Candiani
Journal:  J Bacteriol       Date:  2012-05       Impact factor: 3.490

2.  Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.

Authors:  Julián Larruskain; Pedro Idigoras; José M Marimón; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.

Authors:  Kevin R Marks; Muhammad Malik; Arkady Mustaev; Hiroshi Hiasa; Karl Drlica; Robert J Kerns
Journal:  Bioorg Med Chem Lett       Date:  2011-06-06       Impact factor: 2.823

Review 4.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

5.  In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.

Authors:  Michael J Pucci; Steven D Podos; Jane A Thanassi; Melissa J Leggio; Barton J Bradbury; Milind Deshpande
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

Review 6.  Mycetoma medical therapy.

Authors:  Oliverio Welsh; Hail Mater Al-Abdely; Mario Cesar Salinas-Carmona; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

7.  Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis.

Authors:  Lucio Vera-Cabrera; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Jorge Ocampo-Candiani
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.